Abstract
A radiopharmaceutical consists of a biochemical core linked to a radionuclide emitting radioactive signal that can be detected from outside the body providing funcional information. Imaging with singlephoton-emitting radionuclides (radioisotopes of elements) produces both planar images and single-photon emission computed tomography (SPECT) using a gamma camera. Radiopharmaceuticals labeled with positron-emitting radionuclides are used for positron emission tomography imaging (as described in Chap. 3 of this book “Positron-emitting radiopharmaceuticals”), while radiopharmaceuticals emitting predominantly β or α-particles are used for therapeutic purposes (as described in Chap. 4 of this book). The diagnostic information provided by scintigraphic images derives from the specific distribution of a radiopharmaceutical within the body. The chemical and physical characteristics of a radiopharmaceutical are the main factors determining its accumulation and retention in normal and diseased tissues of the organism. The radionuclides most frequently used for diagnostic applications in conventional nuclear medicine are the isotopes of technetium, iodine, indium, gallium, and thallium. This chapter classifies radiopharmaceuticals according to radionuclide used for labeling and to the main mechanism(s) of tissue localization responsible for the specific distribution properties of the imaging agent.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
DOTA = tetraazacyclododecane-1,4,7,10-tetraacetic acid
References
Lassmann MS, Treves T, For the EANM/SNMMI Paediatric Dosage Harmonization Working Group. Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines. Eur J Nucl Med Mol Imaging. 2014;41:1636. Accessible at: http://www.eanm.org/publications/dosage-card/.
Williams JG. Pertechnetate and the stomach. A continuing controversy. J Nucl Med. 1983;24:63–6.
ICRP. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. ICRP publication 128. Ann ICRP. 2015;44(2S):7.
Eckelman W, Richards P. Instant 99mTc-DTPA. J Nucl Med. 1970;11:761.
Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med. 1986;27:111–6.
Alazraki N, Aarsvold JN, Audisio RA, Glass E, Grant SF, Kunikowska J, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2014;41:1259–60.
Fazzi P, Borsò E, Albertelli R, Mariani G, Giuntini C. Comparative performance of two inhaler systems to assess distribution of convective ventilation by 99mTc-labeled aerosol scintigraphy in patients with airway obstruction. Q J Nucl Med Mol Imaging. 2009;53:428–36.
Abrams MJ, Davison A, Jones AG, et al. Synthesis and characterization of hexakis (alkylisocyanide) and hexakis (arylisocyanide complexes of Technetium (I)). Inorg Chem. 1983;22:2798.
Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99mTc-Sestamibi – a new agent for parathyroid imaging. Nucl Med Commun. 1989;10:791–4.
Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg. 1994;178:49–7.
Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med. 1993;34:222.
ICRP. Radiation dose to patients from radiopharmaceuticals. ICRP publication 53. Ann ICRP. 1988;18(1-4):149.
Nickers NM, Collier B. Drugs inhibiting adrenergic nerves and structures innervated by them. In: Goodman LS, Gilman A, editors. The pharmacological basis of therapeutics. 5th ed. New York, NY: Macmillan Publishing Co; 1975. p. 553–64.
Short JH, Darby TD. Sympathetic nervous system blocking agents. III. Derivatives of benzylguanidine. J Med Chem. 1967;10:833–40.
Wieland DM, Wu J, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with[131I]Iodobenzylguanidine. J Nucl Med. 1980;21:349–53.
Edwards CL, Hayes RL. Tumor scanning with 67Ga citrate. J Nucl Med. 1969;10:103–5.
Kropp J, Buhr W, Bockisch A, Grünwald F, Ruhlmann J, Hotze A, Biersack HJ. Inhalation scintigraphy of the lung using the new ultrafine aerosol Technegas. Nuklearmedizin. 1989;28:46.
Knipping HW, Bolt W, Venrath H, Valentin H, Ludes H, Endler P. A new method of heart and lung function testing, the regional functional analysis in the lung and heart clinic by the radioactive noble gas xenon 133 (isotope thoracography). Dtsch Med Wochenschr. 1955;80:1146–7.
Suggested Readings
Ell PJ, Gambhir SS, editors. Nuclear medicine in clinical diagnosis and treatment. 3rd ed. New York, NY: Churchill Livingston; 2004.
Herbert JC, Eckelman WC, Neumann RD, editors. Nuclear medicine – diagnosis and therapy. New York, NY: Thieme Medical Publishers; 1996.
IAEA. Good practice for introducing radiopharmaceuticals for clinical use. Vienna: International Atomic Energy Agency (IAEA; 2015.
IAEA. Operational guidance on hospital radiopharmacy. Vienna: International Atomic Energy Agency (IAEA); 2008.
IAEA. Radiopharmaceuticals for sentinel lymph node detection: status and trends. Vienna: International Atomic Energy Agency (IAEA); 2015.
IAEA. Technetium-99m radiopharmaceuticals: status and trends. Vienna: International Atomic Energy Agency (IAEA); 2010.
Kowalsky RJ, Falen SW, editors. Radiopharmaceuticals in nuclear pharmacy and nuclear medicine. 3rd ed. Washington, DC: American Pharmacists Association; 2011.
Owunwanne A, Patel M, Sadek S, editors. The handbook of radiopharmaceuticals. New York, NY: Springer; 1995.
Schwochau K, editor. Technetium: chemistry and radiopharmaceuticals. Hoboken, NJ: Wiley; 2000.
Subramanian G, Rhodes BA, Cooper JF, Sodd VJ. Radiopharmaceuticals. New York, NY: Society of Nuclear Medicine; 1975.
Theobald T, editor. Sampson’s textbook of radiopharmacy. 4th ed. London: Pharmaceutical Press; 2010.
Vallabhajosula S. Molecular imaging – radiopharmaceuticals for PET and SPECT. Berlin: Springer; 2009.
Welch MJ, Redvanly CS, editors. Handbook of radiopharmaceuticals: radiochemistry and applications. Hoboken, NJ: Wiley; 2003.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Orsini, F., Puta, E., Guidoccio, F., Mariani, G. (2019). Single-Photon-Emitting Radiopharmaceuticals. In: Volterrani, D., Erba, P.A., Carrió, I., Strauss, H.W., Mariani, G. (eds) Nuclear Medicine Textbook. Springer, Cham. https://doi.org/10.1007/978-3-319-95564-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-95564-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95563-6
Online ISBN: 978-3-319-95564-3
eBook Packages: MedicineMedicine (R0)